Johnson & Johnson is a company in the U.S. stock market and it is a holding in 249 U.S.-traded ETFs. JNJ has around 192.5M shares in the U.S. ETF market. The largest ETF holder of JNJ is the SPDR S&P 500 ETF Trust (SPY), with approximately 29.34M shares. Investors may also find of interest that the ETF with the largest allocation to JNJ stock is iShares U.S. Pharmaceuticals ETF (IHE), with a portfolio weight of 23.16%. On average, U.S. ETFs allocate 2.19% of JNJ to their portfolios.
Additionally, JNJ is a favorite stock for Multi-factor and Vanilla ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with JNJ as a holding is the Reality Shares DIVCON Dividend Defender ETF (DFND), with a return of 5.54%.